Pro12Ala substitution in peroxisome proliferator-activated receptorγ2 is associated with low adiponectin concentrations in young Japanese men

Metabolism: Clinical and Experimental

Volumn 53, Issue 12, 2004, Pages 1548-1551

  Takata, Nobuki ^a   Awata, Takuya ^a   Inukai, Kouichi ^a   Watanabe, Masaki ^a   Ohkubo, Tomoko ^a   Kurihara, Susumu ^a   Inaba, Munemichi ^a   Katayama, Shigehiro ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BODY MASS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; INSULIN SENSITIVITY; MALE; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS;

ADIPONECTIN; ADULT; AMINO ACID SUBSTITUTION; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; GENOTYPE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; MALE; MULTIVARIATE ANALYSIS; PPAR GAMMA; REGRESSION ANALYSIS;

EID: 9344231937     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.06.022     Document Type: Article

References (21)

1. Kubota N., Terauchi Y., Miki H., et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell. 4:1999;597-609
2. Yen C.J., Beamer B.A., Negri C., et al. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians Identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun. 241:1997;270-274
3. Deeb S.S., Fajas L., Nemoto M., et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 20:1998;284-287
4. Hara K., Okada T., Tobe K., et al. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun. 271:2000;212-216
5. Mori H., Ikegami H., Kawaguchi Y., et al. The Pro12→Ala substitution in PPAR-gamma is associated with resistance to development of diabetes in the general population Possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes. 50:2001;891-894
6. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 257:1999;79-83
7. Weyer C., Funahashi T., Tanaka S., et al. Hypoadiponectinemia in obesity and type 2 diabetes Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 86:2001;1930-1935
8. Hotta K., Funahashi T., Arita Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 20:2000;1595-1599
9. Ouchi N., Kihara S., Arita Y., et al. Novel modulator for endothelial adhesion molecules Adipocyte-derived plasma protein adiponectin. Circulation. 100:1999;2473-2476
10. Yang W.S., Lee W.J., Funahashi, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. (erratum in J Clin Endocrinol Metab 87: 1626, 2002) J Clin Endocrinol Metab. 86:2001;3815-3819
11. Maeda N., Takahashi M., Funahashi, et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 50:2001;2094-2099
12. Iwaki M., Matsuda M., Maeda N., et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes. 52:2003;1655-1663
13. Yamamoto Y., Hirose H., Miyashita K., et al. PPAR(gamma)2 gene Pro12Ala polymorphism may influence serum level of an adipocyte-derived protein, adiponectin, in the Japanese population. Metabolism. 51:2002;1407-1409
14. Thamer C., Machicao F., Fritsche A., et al. No influence of the PPARgamma2 Pro12Ala genotype on serum adiponectin concentrations in healthy Europeans. Metabolism. 52:2003;798-799
15. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing Comparison with the euglycemic insulin clamp. Diabetes Care. 22:1999;1462-1470
16. Yang W.S., Jeng C.Y., Wu T.J., et al. Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care. 25:2002;376-380
17. Combs T.P., Wagner J.A., Berger J., et al. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists A potential mechanism of insulin sensitization. Endocrinology. 143:2002;998-1007
18. Yu J.G., Javorschi S., Hevener A.L., et al. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes. 51:2002;2968-2974
19. Nishizawa H., Shimomura I., Kishida K., et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes. 51:2002;2734-2741
20. Altshuler D., Hirschhorn J.N., Klannemark M., et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 26:2000;76-80
21. Maeda N., Shimomura I., Kishida K., et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. 8:2002;731-737